RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Pacific Shuanglin Bio-pharmacy Co Stock

Pacific Shuanglin Bio-pharmacy Co Liabilities 2024

Pacific Shuanglin Bio-pharmacy Co Liabilities

1.2 B CNY

Ticker

000403.SZ

ISIN

CNE000000F14

In 2024, Pacific Shuanglin Bio-pharmacy Co's total liabilities amounted to 1.2 B CNY, a 7.81% difference from the 1.11 B CNY total liabilities in the previous year.

Pacific Shuanglin Bio-pharmacy Co Aktienanalyse

What does Pacific Shuanglin Bio-pharmacy Co do?

Pacific Shuanglin Bio-pharmacy Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Pacific Shuanglin Bio-pharmacy Co's Liabilities

Pacific Shuanglin Bio-pharmacy Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Pacific Shuanglin Bio-pharmacy Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Pacific Shuanglin Bio-pharmacy Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Pacific Shuanglin Bio-pharmacy Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Pacific Shuanglin Bio-pharmacy Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Pacific Shuanglin Bio-pharmacy Co stock

What is the level of liabilities of Pacific Shuanglin Bio-pharmacy Co this year?

Pacific Shuanglin Bio-pharmacy Co has a debt balance of 1.2 B CNY this year.

What were the liabilities of Pacific Shuanglin Bio-pharmacy Co compared to the previous year?

The liabilities of Pacific Shuanglin Bio-pharmacy Co have increased by 7.81% increased compared to the previous year.

What are the consequences of high debt for investors of Pacific Shuanglin Bio-pharmacy Co?

High liabilities can pose a risk for investors of Pacific Shuanglin Bio-pharmacy Co, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Pacific Shuanglin Bio-pharmacy Co?

Low liabilities mean that Pacific Shuanglin Bio-pharmacy Co has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Pacific Shuanglin Bio-pharmacy Co affect the company?

An increase in liabilities of Pacific Shuanglin Bio-pharmacy Co can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Pacific Shuanglin Bio-pharmacy Co affect the company?

A decrease in the liabilities of Pacific Shuanglin Bio-pharmacy Co can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Pacific Shuanglin Bio-pharmacy Co?

Some factors that can influence the liabilities of Pacific Shuanglin Bio-pharmacy Co include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Pacific Shuanglin Bio-pharmacy Co so important for investors?

The liabilities of Pacific Shuanglin Bio-pharmacy Co are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Pacific Shuanglin Bio-pharmacy Co take to modify the liabilities?

To change its liabilities, Pacific Shuanglin Bio-pharmacy Co can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Pacific Shuanglin Bio-pharmacy Co pay?

Over the past 12 months, Pacific Shuanglin Bio-pharmacy Co paid a dividend of 0.08 CNY . This corresponds to a dividend yield of about 0.35 %. For the coming 12 months, Pacific Shuanglin Bio-pharmacy Co is expected to pay a dividend of 0.09 CNY.

What is the dividend yield of Pacific Shuanglin Bio-pharmacy Co?

The current dividend yield of Pacific Shuanglin Bio-pharmacy Co is 0.35 %.

When does Pacific Shuanglin Bio-pharmacy Co pay dividends?

Pacific Shuanglin Bio-pharmacy Co pays a quarterly dividend. This is distributed in the months of August, August, August, July.

How secure is the dividend of Pacific Shuanglin Bio-pharmacy Co?

Pacific Shuanglin Bio-pharmacy Co paid dividends every year for the past 5 years.

What is the dividend of Pacific Shuanglin Bio-pharmacy Co?

For the upcoming 12 months, dividends amounting to 0.09 CNY are expected. This corresponds to a dividend yield of 0.37 %.

In which sector is Pacific Shuanglin Bio-pharmacy Co located?

Pacific Shuanglin Bio-pharmacy Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Pacific Shuanglin Bio-pharmacy Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Pacific Shuanglin Bio-pharmacy Co from 6/28/2024 amounting to 0.2 CNY, you needed to have the stock in your portfolio before the ex-date on 6/28/2024.

When did Pacific Shuanglin Bio-pharmacy Co pay the last dividend?

The last dividend was paid out on 6/28/2024.

What was the dividend of Pacific Shuanglin Bio-pharmacy Co in the year 2023?

In the year 2023, Pacific Shuanglin Bio-pharmacy Co distributed 0.056 CNY as dividends.

In which currency does Pacific Shuanglin Bio-pharmacy Co pay out the dividend?

The dividends of Pacific Shuanglin Bio-pharmacy Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Pacific Shuanglin Bio-pharmacy Co

Our stock analysis for Pacific Shuanglin Bio-pharmacy Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pacific Shuanglin Bio-pharmacy Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.